trending Market Intelligence /marketintelligence/en/news-insights/trending/BOMNOS_nI_s08Mi2cL0iJA2 content esgSubNav
In This List

Kala Pharmaceuticals president/chief business officer steps down

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Kala Pharmaceuticals president/chief business officer steps down

Kala Pharmaceuticals, Inc. said Charles McDermott stepped down as president and chief business officer on Aug. 7.

Mark Iwicki, who has been CEO and chairman of the company's board since September 2015, took over the additional role of president.

Iwicki previously served as CEO and president of biopharmaceutical company Civitas Therapeutics Inc.

McDermott's resignation was not due to any disagreement with Kala Pharmaceuticals.